Assessment of Exenatide Extended‐Release for Maintenance of Diabetic Remission in Cats

Assessment of Exenatide Extended‐Release for Maintenance of Diabetic Remission in Cats

ABSTRACT Background Insulin‐treated diabetic cats frequently achieve transient remission. The glucagon‐like peptide‐1 receptor agonist, exenatide extended‐release (exenatide‐ER), preserves β cell function in people with type 2 diabetes mellitus (DM). Objectives Investigate the effect of exenatide‐ER...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chen Gilor, Linda M. Fleeman, Sean E. Hulsebosch, Stijn J. M. Niessen, Charlotte R. Bjørnvad, Jully Pires, Katarina Hazuchova, Jocelyn Mott, Allison L. O'Kell, Ruth Gostelow, Adam J. Rudinsky, Audrey K. Cook
Format:	Article
Language:	English
Published:	Wiley 2025-03-01
Series:	Journal of Veterinary Internal Medicine
Subjects:	diabetes mellitus feline GLP‐1 glucagon remission weight loss
Online Access:	https://doi.org/10.1111/jvim.70069
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Exenatide and glucagon co-infusion increases myocardial glucose uptake and improves markers of diastolic dysfunction in adults with type 2 diabetes
by: James Goodman, et al.
Published: (2025-07-01)

Pharmalogical effects and results of clinical trials of the first incretinomimetic exenatide
by: Alexander Sergeevich Ametov, et al.
Published: (2011-09-01)

Prevalence of selected infectious agents in Swedish cats with fever and/or anemia compared to cats without fever and/or anemia and to stable/stray cats
by: Gunilla Ölmedal, et al.
Published: (2025-05-01)

Comparison of the Changes in Quality-of-Life of Cats with Hyperthyroidism Treated with Radioiodine or Antithyroid Drugs—A Preliminary Study
by: Fabienne Blunschi, et al.
Published: (2025-06-01)

GLP-1 and Its Role in Glycogen Production: A Narrative Review
by: Joseph Lotosky, et al.
Published: (2025-06-01)

Effect of high intakes of protein-only and carbohydrate-only on plasma metabolites and hormones, in addition to nitrogen excretion
by: Matthieu Clauss, et al.
Published: (2025-08-01)

The Neuroprotective Effects of GLP-1 Analogues on Alzheimer's Disease – A Literature Review
by: Wiktoria Ulicka, et al.
Published: (2025-04-01)

Emergency Dyspnea in 258 Cats: Insights from the French RAPID CAT Study
by: Nour Abboud, et al.
Published: (2025-03-01)

A Case Series on the Efficacy of the Pharmacological Treatment of Lipedema: The Italian Experience with Exenatide
by: Laura Patton, et al.
Published: (2025-07-01)

Long‐Term Clinical Response to Medical Treatment, Behavioral Therapy, or Their Combination in Cats With Hyperesthesia Syndrome
by: Claudia Pauciulo, et al.
Published: (2025-07-01)

Detection of Feline Coronavirus RNA in Cats with Feline Infectious Peritonitis and Their Housemates
by: Phoenix M. Shepherd, et al.
Published: (2025-07-01)

Stabilization of remission in patients with opioid depen dence: pharmacological and pharmacogenetic aspects
by: V. Ya. Palatkin, et al.
Published: (2016-12-01)

Glucagon and Glucose Availability Influence Metabolic Heterogeneity and Malignancy in Pancreatic Neuroendocrine Tumour (pNET) Cells: Novel Routes for Therapeutic Targeting
by: Bárbara Ferreira, et al.
Published: (2025-06-01)

Prospective Evaluation of the Prevalence and Laboratory Findings in Adult Cats with Low Thyroxine and Increased Thyrotropin Concentration
by: Joanna Lin, et al.
Published: (2024-12-01)

Physiology and pharmacology of glucagon-like peptide-1 receptor
by: D. V. Kurkin, et al.
Published: (2024-01-01)

The role of human glucagon-like peptide-1 analog in therapy of type 2 dianetes mellitus
by: Marina Vladimirovna Shestakova
Published: (2010-09-01)

Impact of completely histological remission on reducing flare-ups in moderate-to-severe, biologics-experienced ulcerative colitis patients with endoscopic remission
by: Zih-Hao Wei, et al.
Published: (2025-08-01)

Filgrastim Efficiency in Cats Naturally Infected with Feline Panleukopenia Virus
by: Mihaela Anca Dascalu, et al.
Published: (2024-12-01)

RHEUMATOID ARTHRITIS: THE PROBLEMS OF REMISSION AND THERAPY RESISTANCE
by: E. L. Nasonov, et al.
Published: (2018-07-01)

EPILEPSIES WITH PYREXIAL REMISSIONS
by: L. V. Shalkevich
Published: (2015-04-01)

Response and remission after first-line corticosteroid therapy in primary immune thrombocytopenia
by: D Mapimhidze, et al.
Published: (2025-02-01)

Molecular investigation of feline herpesvirus 1 (fhv-1) and feline calicivirus in cats with respiratory system problem
by: Seval Bilge Dağalp, et al.

Effects of Metronidazole on the Fecal Microbiota, Fecal Metabolites, and Serum Metabolites of Healthy Adult Cats
by: Sara E. Martini, et al.
Published: (2025-04-01)

Diabetes Remission: Myth or Reality?
by: Ashok Kumar, et al.
Published: (2023-01-01)

Circulus arteriosus formation in cat brain
by: Marcelo Salvador Gomes, et al.

Single Enema Fecal Microbiota Transplantation in Cats With Chronic Enteropathy
by: Dimitra A. Karra, et al.
Published: (2025-05-01)

The Age Standardized Remission Rate of Acute Myeloid Leukemia in Adults
by: Sana Hashmat, et al.
Published: (2024-12-01)

Remission of diabetes mellitus in an intact female dog
by: Jéssica Queiroz, et al.
Published: (2024-05-01)

Clinical-laboratory evaluation of overweight and obese cats seen in routine clinical practice
by: Steffi L. Araujo, et al.
Published: (2025-07-01)

Decreased incidence of hidradenitis suppurativa and psoriasis in diabetic patients treated with GLP-1 receptor agonists: A retrospective cohort study
by: Lauren M. Ching, BS, et al.
Published: (2025-10-01)

Unilateral perineal hernia in female cat - case report
by: D.P. Alves, et al.
Published: (2025-02-01)

Association of Serum Symmetric Dimethylarginine Concentrations and Inflammation in Cats
by: Giulia Cattaneo, et al.
Published: (2025-03-01)

Sustained remission in large-Vessel vasculitis: Do they ever burn out?
by: Sakir Ahmed, et al.
Published: (2019-01-01)

ADALIMUMAB DISCONTINUATION IN PATIENTS WITH RHEUMATOID ARTHRITIS AFTER ACHIEVING SUSTAINED REMISSION
by: N. V. Demidova, et al.
Published: (2018-07-01)

Can remission be in juvenile idiopathic arthritis without the use of biological agents?
by: S. I. Valieva, et al.
Published: (2019-09-01)

Protective efficacy of inactivated FHV-1 vaccine in cats following challenge with the Chinese field strains
by: Yujie Jiang, et al.
Published: (2025-04-01)

Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis
by: Mariele Gatto, et al.
Published: (2024-04-01)

Problems of low activity and remission in systemic lupus erythematosus
by: S. K. Soloviev, et al.
Published: (2019-05-01)

Clinical and functional remission assessment in patients with recurrent depression
by: N. N. Petrova
Published: (2019-12-01)

A retrospective study on dystocia in the cat, evaluation of 111 cases
by: Eva Axnér, et al.
Published: (2025-04-01)